COMMUNIQUÉS West-GlobeNewswire

BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family

29/08/2024 - 14:30

SUNNYVALE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today [...]

Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking

29/08/2024 - 14:30

The Company Showed a Substantial Reduction in the Physical, Negative Characteristics that Accompany Heavy Drinking in its Recent Groundbreaking, Clinical Study JUPITER, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Safety [...]

Can-Fite Reports First Half 2024 Financial Results & Progress in Two Pivotal Phase III Clinical Studies

29/08/2024 - 14:15

RAMAT GAN, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological [...]

ORYZON to Provide Corporate Progress Updates at Several Events in September

29/08/2024 - 14:14

German Fall Conference 2024 European College of Neuropsychopharmacology (ECNP) congress 2024 Sachs Annual Biotech in Europe Forum 2024 MADRID, Spain and CAMBRIDGE, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Oryzon [...]

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

29/08/2024 - 14:00

FLORHAM PARK, N.J., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) [...]

Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers

29/08/2024 - 14:00

FORT LEE, N.J., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative precision [...]

EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

29/08/2024 - 14:00

LYON, France, August 29, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in a fireside chat and [...]

Alignment Health Plan Ranks No. 2 in Customer Satisfaction Among Medicare Advantage Plans in California in J.D. Power Study

29/08/2024 - 14:00

ORANGE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Alignment Healt h , the consumer brand name for Alignment Healthcare (NASDAQ: ALHC), today announced Alignment Health Plan has ranked No. 2 in customer satisfaction in [...]

Foundation for Sarcoidosis Research Expands Scientific Advisory Board with 14 New Experts to Enhance Sarcoidosis Research and Patient Care

28/08/2024 - 22:48

CHICAGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, [...]

Celularity Appoints Richard J. Berman to its Board of Directors

28/08/2024 - 22:45

Seasoned Public Company Director and Finance Veteran Brings Extensive Track Record of Success in Facilitating the Growth of Shareholder Value FLORHAM PARK, N.J., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq [...]

Spectral AI to Participate in Upcoming Investor Conferences

28/08/2024 - 22:30

DALLAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

iTeos to Participate in Upcoming Investor Conferences

28/08/2024 - 22:30

WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 28, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new [...]

Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

28/08/2024 - 22:15

ROCKVILLE, Md., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]

CooperCompanies Announces Third Quarter 2024 Results

28/08/2024 - 22:15

SAN RAMON, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2024. Revenue [...]

Akero Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

28/08/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked [...]

Lyell Immunopharma Announces Participation in September Investor Conferences

28/08/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with [...]

Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

28/08/2024 - 22:05

WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and [...]

ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

28/08/2024 - 22:05

SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside [...]

QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases

28/08/2024 - 22:05

New agreement expands collaboration with AstraZeneca beyond oncology, including complex chronic diseases // QIAGEN’s syndromic testing platform QIAstat-Dx enables specialty care providers to make fast decisions about [...]